Understanding Lupus Anticoagulant (dRVVT) LA 2 Confirm: Normal vs Optimal Ranges

?What is Lupus Anticoagulant (dRVVT) LA 2 Confirm?

The lupus anticoagulant (LA) confirmatory test using dilute Russell viper venom time (dRVVT) is a specialized coagulation study used to detect the presence of lupus anticoagulant, an antibody that can prolong clotting times in vitro. This test is the confirmatory step following an initial screening LA test and helps distinguish true lupus anticoagulant from other causes of prolonged activated partial thromboplastin time (aPTT). Lupus anticoagulant is associated with antiphospholipid syndrome and increased thrombotic risk, despite its in vitro anticoagulant effect.

!Why It Matters

A positive lupus anticoagulant test may suggest antiphospholipid syndrome, which can be associated with an increased risk of blood clots (thrombosis), recurrent pregnancy loss, and stroke. This marker helps identify individuals who may need anticoagulation therapy or closer monitoring. Early detection of lupus anticoagulant can inform clinical management and reduce the risk of thromboembolic complications.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• History of unexplained blood clots or deep vein thrombosis
• Recurrent miscarriages or pregnancy complications
• Stroke or transient ischemic attack at a young age
• Prolonged bleeding or bruising
• Joint pain and inflammation

How to Improve Your Levels

• 1Follow anticoagulation therapy as prescribed by your physician if lupus anticoagulant is confirmed
• 2Regular monitoring with repeat testing and clinical assessment per rheumatology or hematology guidance
• 3Avoid smoking and maintain cardiovascular health to reduce thrombotic risk
• 4Manage any underlying autoimmune conditions under specialist care
• 5Maintain adequate hydration and avoid prolonged immobility
• 6Work with your healthcare team to optimize management during pregnancy if applicable

When to Test

Testing is indicated when screening LA tests (such as aPTT) are prolonged and not corrected by mixing studies, when evaluating recurrent thrombosis or pregnancy loss, when assessing for antiphospholipid syndrome, or when monitoring known lupus anticoagulant-positive patients.

Related Biomarkers